SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-047478
Filing Date
2018-08-17
Accepted
2018-08-17 17:24:54
Documents
2
Period of Report
2018-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9092
2 POA DOCUMENT poa.txt EX-24.3_806145 3898
  Complete submission text file 0001209191-18-047478.txt   14536
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 11 TIMES SQUARE, 33RD FLOOR NEW YORK NY 10036
Business Address
Lombardo Ilise (Reporting) CIK: 0001750158 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37418 | Film No.: 181026600